Brief: Theravance Biopharma Q3 Operating Income USD -10.837 Million
12/11/2024 21:05
Nov 12 (Reuters) - Theravance Biopharma Q3 net income USD -12.698 million. * Q3 adjusted net income USD -2.897 million vs. IBES estimate USD -11.2 million
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy